Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
hDMT (Institute for human Organ and Disease Model Technologies) is a non-profit R&D consortium based in the Netherlands that specializes in Organ-on-a-Chip (OoC) technology. The organization facilitates collaboration between academic institutions, medical centers, and industrial partners to develop advanced human-relevant in vitro models that mimic the functions of human organs. By integrating microfluidics, tissue engineering, and stem cell biology, hDMT aims to improve drug development efficiency and reduce reliance on animal testing. Their work spans various therapeutic areas, providing standardized platforms for studying disease mechanisms and testing new therapeutic interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on hDMT.